Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Total Debt: 2012-2022

Historic Total Debt for Altimmune (ALT) over the last 10 years, with Dec 2022 value amounting to $4.6 million.

  • Altimmune's Total Debt was N/A to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year change of. This contributed to the annual value of $4.6 million for FY2022, which is 39.28% down from last year.
  • Altimmune's Total Debt amounted to $4.6 million in FY2022, which was down 39.28% from $7.5 million recorded in FY2021.
  • Altimmune's Total Debt's 5-year high stood at $7.5 million during FY2021, with a 5-year trough of $1.8 million in FY2020.
  • For the 3-year period, Altimmune's Total Debt averaged around $4.7 million, with its median value being $4.6 million (2022).
  • As far as peak fluctuations go, Altimmune's Total Debt tumbled by 59.51% in 2018, and later spiked by 312.59% in 2021.
  • Altimmune's Total Debt (Yearly) stood at $1.9 million in 2018, then rose by 0.69% to $1.9 million in 2019, then fell by 1.95% to $1.8 million in 2020, then soared by 312.59% to $7.5 million in 2021, then crashed by 39.28% to $4.6 million in 2022.